US Patent Issued to Flamel Ireland on May 13 for "Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics" (French Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,926, issued on May 13, was assigned to Flamel Ireland Ltd. (Dublin).

"Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics" was invented by Julien Grassot (Lyons, France), David Monteith (Lyons, France), Herve Guillard (Villeurbanne, France), Claire Megret (Lyons, France) and Jean-Francois Dubuisson (Lyons, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof."

The patent was filed on April 28, 2022, under Application No. 17/731,562.

*For further information, i...